Speaker Profile
MD, Chief Medical Officer, Affini-T Tx
Biography
Dirk Nagorsen has 25 years of experience in oncology, both as clinical researcher and as drug developer. He is the Chief Medical Officer at AffiniT, a precision immunotherapy company targeting cancer driver mutations. Previously he was Vice President Global Head Early Development Oncology at Amgen. Before his time there, he worked as Sen Med Director at Micromet, a German biotech, developing bispecific T cell engagers. Dirk earned his medical degree and his habilitation (second scientific degree, equivalent of a PhD) in experimental medicine and tumor immunology from Charité University Medicine Berlin. He trained in internal medicine, hematology, and oncology at the Free University Berlin Medical School, at the NIH Clinical Center Bethesda, Maryland, and at Charité University Medicine Berlin.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF
